US5344393A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Use of synthetic oxygen carriers to facilitate oxygen delivery
Assignee: PFC Therapeutics LLC
•
Filing: 1992-02-28
•
Granted: 1994-09-06
•
Expires: 2012-02-28
Abstract
Abstract A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of removing and preferably storing a portion of the patient's blood, intravenously administering a biocompatible liquid in sufficient quantity to substantially maintain the patient's hemodynamic stability, wherein the liquid comprises an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier, after which the patient undergoes a loss of blood, and then readministering blood to the patient, preferably the stored blood. In one embodiment, the biocompatible liquid further comprises a hemodiluent and the hemodiluent is administered separately from the oxygen carrier.
Inventors
- 👤 Duane J. Roth
- 👤 Peter E. Keipert
- 👤 Nicholas S. Faithfull
- 👤 Thomas F. Zuck
- 👤 Jean G. Riess
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 21:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/02; A61K38/00; A61K38/16; A61K38/41; A61K38/42; A61M; A61M1/00; A61M1/02; A61P; A61P7/00; A61P7/08; A61M2202/00; A61M2202/04; A61M2202/0468; A61M2202/0476
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
99 words
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of: removing and storing a portion of the patient's blood; intravenously administering a biocompatible liquid in sufficient quantity to maintain the patient's blood volume, wherein said liquid comprises an effective oxygen-delivery enhancing amount of a synthetic biocompatible oxygen carrier; having said patient undergo a loss of blood subsequent to the administration of the biocompatible liquid; administering breathing gas enriched with a concentrated of 50%-100% oxygen to said patient during said loss of blood; and readministering said stored blood to said patient.
Claim 2
Independent Claim
99 words
A method for facilitating autologous blood use by a patient facing a loss of blood, comprising the steps of: removing and storing a portion of the patient's blood; intravenously administering a biocompatible liquid in sufficient quantity to maintain the patient's blood volume, wherein said liquid comprises an effective oxygen-delivery enhancing amount of a synthetic biocompatible oxygen carrier; having said patient undergo a loss of blood subsequent to the administration of the biocompatible liquid; administering breathing gas enriched with a concentrated of 50%-100% oxygen to said patient during said loss of blood; and readministering said stored blood to said patient.
Claim 3
Dependent Claim
24 words
The method of claim 1, wherein the biocompatible liquid further comprises a hemodiluent and wherein said hemodiluent is administered separately from said oxygen carrier.
Claim 4
Dependent Claim
18 words
The method of claim 1, wherein the oxygen carrier is derived from human, animal, plant, or recombinant hemoglobin.
Claim 5
Dependent Claim
13 words
The method of claim 1, wherein the oxygen carrier is a fluorocarbon emulsion.
Claim 6
Dependent Claim
32 words
The method of claim 2, wherein the said oxygen carrier is a fluorocarbon emulsion and the volume of said administered oxygen carrier is less than 50% of the volume of said hemodiluent.
Claim 7
Dependent Claim
17 words
The method of claim 4, wherein said fluorocarbon emulsion has a concentration of at least 40%, w/v.
Claim 8
Dependent Claim
17 words
The method of claim 6, wherein the concentration of said fluorocarbon emulsion is at least 60%, w/v.
Claim 9
Dependent Claim
17 words
The method of claim 1, wherein said hemodiluent is a crystalloid, a colloid, or a combination thereof.
Claim 10
Dependent Claim
13 words
The method of claim 1, wherein said blood loss is associated with surgery.
Claim 11
Dependent Claim
13 words
The method of claim 1, wherein said blood loss is associated with trauma.
Claim 12
Dependent Claim
27 words
The method of claim 1, wherein the amount of oxygen carrier administered is between about 0.5 and 10 g/kg, based on the body weight of the patient.
Claim 13
Dependent Claim
12 words
The method of claim 1, wherein said biocompatible liquid includes a hemodiluent.
Claim 14
Dependent Claim
28 words
The method of claim 1, wherein said quantity of biocompatible liquid is from about 75% to about 300% of the volume of blood removed in said removing step.
Claim 15
Dependent Claim
26 words
The method of claim 9, further comprising the step of administering an additional amount of a biocompatible synthetic oxygen carrier to said patient during said surgery.
Claim 16
Independent Claim
122 words
A method for facilitating autologous blood use by a patient facing a loss of blood during surgery, comprising the steps of: removing and storing a portion of the patient's blood; intravenously administering a hemodiluent to said patient in conjunction with the removing step in a volume at least as great as the volume of blood removed, thereby increasing the cardiac output of the patient; thereafter initiating a surgical procedure on said patient, said surgical procedure involving a loss of blood; administering an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier to said patient during said surgical procedure; and administering a breathing gas to said patient during said surgical procedure, said breathing gas being enriched with a concentration of 50%-100% oxygen.
Claim 17
Independent Claim
122 words
A method for facilitating autologous blood use by a patient facing a loss of blood during surgery, comprising the steps of: removing and storing a portion of the patient's blood; intravenously administering a hemodiluent to said patient in conjunction with the removing step in a volume at least as great as the volume of blood removed, thereby increasing the cardiac output of the patient; thereafter initiating a surgical procedure on said patient, said surgical procedure involving a loss of blood; administering an effective oxygen-delivery enhancing amount of a biocompatible synthetic oxygen carrier to said patient during said surgical procedure; and administering a breathing gas to said patient during said surgical procedure, said breathing gas being enriched with a concentration of 50%-100% oxygen.
Claim 18
Dependent Claim
30 words
The method of claim 15, wherein said synthetic oxygen carrier is a fluorocarbon emulsion and the administered volume of fluorocarbon is less than 50% of the volume of said hemodiluent.
Claim 19
Dependent Claim
17 words
The method of claim 15, further comprising the step of readministering said stored blood to said patient.
References Cited (Backward Citations)
US3482575A
Cited
US3975512A
Cited
US4073879A
Cited
US4275726A
Cited
US4301144A
Cited
US4981691A
Cited
US4777244A
Cited
US4473494A
Cited
US4698387A
Cited
US4526715A
Cited
US4600531A
Cited
US4963130A
Cited
EP0231070A2
Cited
US4927623A
Cited
US4987154A
Cited
US5080885A
Cited
US4911929A
Cited
US4861867A
Cited
US5130230A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-09-05 | 1998-03-07 | 1998-09-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-09-05 | 2002-03-07 | 2002-09-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-09-05 | 2006-03-07 | 2006-09-06 | $7700.00 | Window Closed / Lapsed |